Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Clover Health Investments, Corp. - Class A Common stock
(NQ:
CLOV
)
1.720
-0.030 (-1.71%)
Official Closing Price
Updated: 4:15 PM EDT, Mar 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clover Health Investments, Corp. - Class A Common stock
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Social Capital Hedosophia Holding Corp. III’s Directors and Officers for Breach of Fiduciary Duties – IPOC, CLOV
March 23, 2023
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 28, 2023
Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early...
Via
Benzinga
Why Clover Health Stock Is Rising Today
↗
February 28, 2023
Clover Health Investments Corp (NASDAQ: CLOV) shares are trading higher Tuesday after the company reported strong fourth-quarter results.
Via
Benzinga
Citigroup Maintains Neutral Rating for Clover Health Investments: Here's What You Need To Know
↗
November 16, 2022
Via
Benzinga
Can Q4 Results Help Save Clover Health (CLOV) Stock?
↗
February 28, 2023
Clover Health (CLOV) stock is on the rise Tuesday thanks to the company's earnings report for the fourth quarter of 2022.
Via
InvestorPlace
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
↗
February 28, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
I ‘Tricked’ ChatGPT Into Picking Stocks to Buy. Here’s What It Said.
↗
February 17, 2023
We asked ChatGPT to name various types of stocks to buy. Can the latest artificial intelligence craze get things right?
Via
InvestorPlace
Clovis Oncology (CLVS) Stock Pops After Bankruptcy Warning
↗
November 14, 2022
Today, speculators are bidding up shares of Clovis Oncology and CLVS stock, after the company announced bankruptcy concerns.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
↗
October 19, 2022
On Wednesday, 200 companies hit new 52-week lows.
Via
Benzinga
CLOVER HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating Clover Health Investments Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 26, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
How Did Stocks React To The December CPI Print? A Tale Of Two Narratives
↗
January 12, 2023
Market bets on whether the Federal Reserve's rate hikes would lead to a recession in 2023 have become a primary focus for the equity markets and for those who trade them.
Via
Benzinga
25 Penny Stocks to Sell Before They Die
↗
December 07, 2022
Wondering which small-cap companies you should offload before 2023? Here are the top picks for penny stocks to sell while you still can.
Via
InvestorPlace
6 Penny Stocks to Sell Right Now … And 1 to Buy
↗
November 17, 2022
Don't be tempted by the ultra-low price of these penny stocks. All of them are likely headed even lower.
Via
InvestorPlace
7 Penny Stocks Smart Investors Shouldn’t Touch With a 10-Foot Pole
↗
November 13, 2022
Don't let the recent bull market rally fool you into thinking these seven penny stocks to avoid are worthwhile moonshots.
Via
InvestorPlace
7 Stocks Only Suckers Will Own In This Bear Market
↗
October 13, 2022
Don't purchase any of these sucker stocks to avoid, as a vicious bear market and increased recession risk drives their prices lower.
Via
InvestorPlace
Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023
October 11, 2022
From
Clover Health Investments, Corp.
Via
GlobeNewswire
Clover Health Debuts New Medicare Advantage Plans for 2023
October 06, 2022
From
Clover Health Investments, Corp.
Via
GlobeNewswire
Billionaire VC Chamath Palihapitiya Sells Clover Health Shares: Is He No Longer Bullish?
↗
October 04, 2022
Once touted as the SPAC King, Chamath Palihapitiya used blank check companies to take several private companies public. But as the SPAC craze dies out, the billionaire venture capitalist is now...
Via
Benzinga
Why Is FaZe Clan (FAZE) Stock Down 34% Today?
↗
October 04, 2022
FaZe Clan (FAZE) stock isn't doing so hot on Tuesday as investors start to lose hope in the e-sports company following its SPAC merger.
Via
InvestorPlace
Is Chamath Palihapitiya Giving Up on Clover Health (CLOV) Stock?
↗
October 04, 2022
CLOV stock needs investors to get through this year's Medicare Advantage marketing wars, but they won't include Chamath Palihapitiya.
Via
InvestorPlace
7 Nasdaq Stocks to Sell Before They Die
↗
September 26, 2022
With more pain ahead for equities, these seven Nasdaq stocks should be the first to be expelled from investors' portfolios.
Via
InvestorPlace
Chamath Palihapitiya Is Giving Up on IPOF, IPOD Stocks
↗
September 20, 2022
Both IPOF stock and IPOD stock are now trading at their IPO prices of $10 after Palihapitiya pulled the plug on the SPACs.
Via
InvestorPlace
Red-Hot IPOF Stock Will Stop Trading Oct. 14. Here’s Why.
↗
September 20, 2022
Shares of IPOF stock are back at its IPO price of $10 after Chamath Palihapitiya announced a return of capital to shareholders.
Via
InvestorPlace
7 Meme Stocks for Investors to Take Seriously in 2022
↗
August 30, 2022
These meme stocks have a remarkable growth runway ahead and are trading near historical lows. I wouldn't count them out just yet.
Via
InvestorPlace
Clover Health Investments, Corp. (NASDAQ:CLOV) Investor Alert: Investigation Concerning Possible Wrongdoing
↗
August 23, 2022
San Diego, CA -- (SBWIRE) -- 08/23/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Clover Health Investments, Corp.
Via
SBWire
Chamath Palihapitiya's SPAC Track Record Means Double-Digit Losses For You. Here Are The Details On All His Deals
↗
August 18, 2022
Chamath Palihapitiya was one of the biggest names in the SPAC market in 2021 and when times were good for new companies going public, Palihapitiya had some of the best-performing deals of that year.
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
↗
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
↗
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
Why Is Norwegian Cruise (NCLH) Stock Down 12% Today?
↗
August 09, 2022
Norwegian Cruise (NCLH) stock is sinking on Tuesday as investors react to the company's earnings report for the second quarter of 2022.
Via
InvestorPlace
Tuesday Morning (TUEM) Stock Rockets 32% Amid Bankruptcy Talk
↗
August 09, 2022
Tuesday Morning (TUEM) stock is soaring higher today as investors boost the shares amid talk of a potential bankruptcy filing.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.